Healthcare provider profile · identity verified

Min Song, MD

Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · MILTON, MA · NPI 1982715256

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Min Song, MD received $180.47 in general payments during 2025 across 3 reported records.

ABBVIE INC. accounted for 69.4% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 62 claims for Creon by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 35 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Synthroid by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 893 claims for Eliquis by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Paxlovid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$180.47

3 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$125.31	69.4%	1	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$55.16	30.6%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$180.47	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
SKYRIZI Normalized: skyrizi	Biological	ABBVIE INC.	$125.31	1	2025
Source payment records 2025-11-05 · ABBVIE INC. · $125.31 · Open Payments source
VELSIPITY Normalized: velsipity	Drug	PFIZER INC.	$29.76	1	2025
Source payment records 2025-12-31 · PFIZER INC. · $29.76 · Open Payments source
VYNDAQEL Normalized: vyndaqel	Drug	PFIZER INC.	$25.40	1	2025
Source payment records 2025-04-28 · PFIZER INC. · $25.40 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	CREON open payments reported associated product	CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608	Creon · 2024 Exact normalized brand match · 1 Part D row	62	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	35	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	SYNTHROID open payments reported associated product	CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636	Synthroid · 2024 Exact normalized brand match · 1 Part D row	23	suppressed by CMS
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063	Eliquis · 2024 Exact normalized brand match · 1 Part D row	893	84
PFIZER INC. Exact reporting entity; no affiliate inference	2025	PAXLOVID open payments reported associated product	CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432	Paxlovid · 2024 Exact normalized brand match · 1 Part D row	19	19

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1549	293
Amlodipine Besylate	Amlodipine Besylate	1136	185
Levothyroxine Sodium	Levothyroxine Sodium	1034	127
Trazodone Hcl	Trazodone Hcl	976	137
Eliquis	Apixaban	893	84
Furosemide	Furosemide	835	89
Gabapentin	Gabapentin	822	123
Omeprazole	Omeprazole	769	143
Losartan Potassium	Losartan Potassium	740	125
Metoprolol Succinate	Metoprolol Succinate	713	113
Sertraline Hcl	Sertraline Hcl	652	72
Quetiapine Fumarate	Quetiapine Fumarate	589	47
Mirtazapine	Mirtazapine	578	92
Pantoprazole Sodium	Pantoprazole Sodium	525	65
Lisinopril	Lisinopril	498	91
Tamsulosin Hcl	Tamsulosin Hcl	476	81
Metoprolol Tartrate	Metoprolol Tartrate	470	45
Donepezil Hcl	Donepezil Hcl	467	69
Potassium Chloride	Potassium Chloride	398	47
Metformin Hcl	Metformin Hcl	374	76
Famotidine	Famotidine	365	46
Clopidogrel	Clopidogrel Bisulfate	309	30
Hydrochlorothiazide	Hydrochlorothiazide	307	52
Simvastatin	Simvastatin	307	52
Duloxetine Hcl	Duloxetine Hcl	297	40
Metformin Hcl Er	Metformin Hcl	284	73
Escitalopram Oxalate	Escitalopram Oxalate	277	38
Tramadol Hcl	Tramadol Hcl	266	76
Rosuvastatin Calcium	Rosuvastatin Calcium	250	43
Fluoxetine Hcl	Fluoxetine Hcl	231	29
Myrbetriq	Mirabegron	228	33
Hydralazine Hcl	Hydralazine Hcl	214	33
Olanzapine	Olanzapine	212	21
Levetiracetam	Levetiracetam	209	25
Allopurinol	Allopurinol	205	33
Pravastatin Sodium	Pravastatin Sodium	200	41
Jardiance	Empagliflozin	191	21
Memantine Hcl	Memantine Hcl	183	16
Celecoxib	Celecoxib	178	48
Carvedilol	Carvedilol	175	25
Memantine Hcl Er	Memantine Hcl	171	23
Divalproex Sodium	Divalproex Sodium	168	22
Torsemide	Torsemide	168	29
Atenolol	Atenolol	155	37
Alendronate Sodium	Alendronate Sodium	154	32
Finasteride	Finasteride	149	31
Fluticasone Propionate	Fluticasone Propionate	141	50
Oxycodone Hcl	Oxycodone Hcl	140	19
Januvia	Sitagliptin Phosphate	133	21
Citalopram Hbr	Citalopram Hydrobromide	123	25
Albuterol Sulfate Hfa	Albuterol Sulfate	112	45
Ozempic	Semaglutide	110	17
Latanoprost	Latanoprost	109	27
Clonazepam	Clonazepam	100	20
Bupropion Xl	Bupropion Hcl	99	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	98	14
Xarelto	Rivaroxaban	97	14
Glimepiride	Glimepiride	96	26
Prednisone	Prednisone	96	22
Labetalol Hcl	Labetalol Hcl	95	16
Azithromycin	Azithromycin	92	48
Ciprofloxacin Hcl	Ciprofloxacin Hcl	88	60
Ezetimibe	Ezetimibe	88	13
Meclizine Hcl	Meclizine Hcl	88	13
Alfuzosin Hcl Er	Alfuzosin Hcl	87	14
Glipizide Er	Glipizide	84	22
Warfarin Sodium	Warfarin Sodium	83	suppressed
Bupropion Hcl Sr	Bupropion Hcl	82	suppressed
Pregabalin	Pregabalin	82	20
Spironolactone	Spironolactone	81	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	80	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	22
Gemfibrozil	Gemfibrozil	75	suppressed
Haloperidol	Haloperidol	75	suppressed
Ondansetron Hcl	Ondansetron Hcl	74	26
Paroxetine Hcl	Paroxetine Hcl	74	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	74	15
Folic Acid	Folic Acid	73	suppressed
Midodrine Hcl	Midodrine Hcl	73	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	71	43
Diltiazem Hcl	Diltiazem Hcl	69	suppressed
Montelukast Sodium	Montelukast Sodium	69	14
Diltiazem 24hr Er	Diltiazem Hcl	66	suppressed
Glipizide	Glipizide	64	14
Baclofen	Baclofen	63	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	19
Acyclovir	Acyclovir	62	suppressed
Creon	Lipase/Protease/Amylase	62	suppressed
Lorazepam	Lorazepam	60	29
Lovastatin	Lovastatin	60	suppressed
Temazepam	Temazepam	60	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	59	suppressed
Sucralfate	Sucralfate	59	13
Tolterodine Tartrate	Tolterodine Tartrate	59	suppressed
Trulicity	Dulaglutide	58	suppressed
Gemtesa	Vibegron	57	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	57	suppressed
Anastrozole	Anastrozole	56	suppressed
Fenofibrate	Fenofibrate	55	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	53	suppressed
Amiodarone Hcl	Amiodarone Hcl	51	suppressed
Nystatin	Nystatin	51	24
Doxycycline Hyclate	Doxycycline Hyclate	50	25
Aripiprazole	Aripiprazole	49	suppressed
Naproxen	Naproxen	49	23
Buspirone Hcl	Buspirone Hcl	48	11
Rivastigmine	Rivastigmine	48	suppressed
Solifenacin Succinate	Solifenacin Succinate	48	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	46	suppressed
Nifedipine Er	Nifedipine	46	suppressed
Alprazolam	Alprazolam	45	suppressed
Hydrocortisone	Hydrocortisone	45	23
Methotrexate	Methotrexate Sodium	44	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	44	12
Tradjenta	Linagliptin	44	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	43	suppressed
Methocarbamol	Methocarbamol	42	suppressed
Tizanidine Hcl	Tizanidine Hcl	42	12
Dutasteride	Dutasteride	41	suppressed
Risperidone	Risperidone	40	11
Lactulose	Lactulose	39	11
Lantus	Insulin Glargine,hum.Rec.Anlog	39	12
Pyridostigmine Bromide	Pyridostigmine Bromide	39	suppressed
Benztropine Mesylate	Benztropine Mesylate	38	suppressed
Carbamazepine	Carbamazepine	38	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	38	19
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	38	suppressed
Ec-Naproxen	Naproxen	38	11
Methenamine Hippurate	Methenamine Hippurate	38	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	36	suppressed
Digoxin	Digoxin	36	suppressed
Timolol Maleate	Timolol Maleate	36	suppressed
Vancomycin Hcl	Vancomycin Hcl	36	suppressed
Betamethasone Valerate	Betamethasone Valerate	35	suppressed
Ibuprofen	Ibuprofen	35	suppressed
Linzess	Linaclotide	35	suppressed
Valsartan	Valsartan	35	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	34	suppressed
Meloxicam	Meloxicam	34	suppressed
Ketoconazole	Ketoconazole	33	13
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Cilostazol	Cilostazol	32	suppressed
Ramelteon	Ramelteon	32	suppressed
Bupropion Hcl	Bupropion Hcl	31	suppressed
Clozapine	Clozapine	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	21
Erythromycin	Erythromycin Base	30	19
Galantamine Er	Galantamine Hbr	30	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	30	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	28	suppressed
Klor-Con M15	Potassium Chloride	27	suppressed
Amantadine	Amantadine Hcl	26	suppressed
Amoxicillin	Amoxicillin	26	17
Carisoprodol	Carisoprodol	26	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	12
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	25	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	25	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	24	suppressed
Nystop	Nystatin	24	17
Oxcarbazepine	Oxcarbazepine	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Albuterol Sulfate	Albuterol Sulfate	23	11
Lamotrigine	Lamotrigine	23	suppressed
Loperamide	Loperamide Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	22	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	16
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	21	suppressed
Cephalexin	Cephalexin	21	13
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	suppressed
Divalproex Sodium Er	Divalproex Sodium	20	suppressed
Humalog	Insulin Lispro	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Novolog	Insulin Aspart	20	suppressed
Brilinta	Ticagrelor	19	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Propranolol Hcl	Propranolol Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	17	17
Exemestane	Exemestane	17	suppressed
Insulin Lispro	Insulin Lispro	17	suppressed
Methazolamide	Methazolamide	17	suppressed
Perphenazine	Perphenazine	17	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	17	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Methimazole	Methimazole	16	suppressed
Sevelamer Hcl	Sevelamer Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Cevimeline Hcl	Cevimeline Hcl	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Nitroglycerin Patch	Nitroglycerin	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Calcium Acetate	Calcium Acetate	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Levofloxacin	Levofloxacin	13	12
Mupirocin	Mupirocin	13	suppressed
Procrit	Epoetin Alfa	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Belsomra	Suvorexant	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Modafinil	Modafinil	12	suppressed
Prednisolone Acetate	Prednisolone Acetate	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	12	suppressed
Acetazolamide	Acetazolamide	11	suppressed
Alphagan P	Brimonidine Tartrate	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Mesalamine Er	Mesalamine	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Sodium Chloride	0.9 % Sodium Chloride	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$180.47 · 3 records	ABBVIE INC.	SKYRIZI, VELSIPITY, VYNDAQEL	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error